ASH 2023: MRD Highlights in BioPharma Drug Development

Read More

Adaptive Reaches 50 Publications

Adaptive’s technology propels research forward in oncology, hematology, infectious disease, transplantation, and autoimmunity, enabling a paradigm shift in understanding human immunology.